Good question. I am no expert, but yes, approval for animal use can be quicker and much cheaper and is often done as a secondary opportunity to human trials. This article is a few years old but explains the difference in simple terms
https://www.linkedin.com/pulse/how-human-veterinary-drugs-go-from-concept-commercial-barksdale
And just to remind us all of the fda fast track approval process we are looking at for btx1801
https://www.fda.gov/drugs/development-approval-process-drugs
Good question. I am no expert, but yes, approval for animal use...
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
0.025(6.58%) |
Mkt cap ! $734.6M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 40.5¢ | 37.5¢ | $3.018M | 7.647M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 211394 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 853 | 2 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |